Drugs / Morphine Sulfate Immediate Release
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03529331 Comparator | Sep 2019 → Dec 2021 | — | Antonios Likourezos | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Morphine Sulfate Immediate Release | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03529331 ↗ |
| Known as | MSIR | “15 mg Morphine Sulfate Immediate Release (MSIR) tablet 4 times a day for 5 days” NCT03529331 ↗ |